In the last three months, 7 analysts have published ratings on Quest Diagnostics (NYSE:DGX), offering a diverse range of perspectives from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $148.57, with a high estimate of $155.00 and a low estimate of $144.00. Witnessing a positive shift, the current average has risen by 3.77% from the previous average price target of $143.17.

Diving into Analyst Ratings: An In-Depth Exploration

In examining recent...